About us
Transcranial Magnetic Stimulation (TMS) has quickly become a new treatment option for depression since it was approved for clinical use by the Ministry of Health and Welfare in 2018. The Taiwan Clinical TMS Society (TCTMSS) was established in September 2021 with the goal of bringing together medical professionals from various fields across Taiwan to jointly develop the clinical application of TMS. This platform allows practitioners to gain the latest knowledge, exchange clinical experiences, and enhance their treatment skills, thereby promoting the steady development of this emerging therapy.
The purpose of establishing this association:
- Raise the awareness of TMS in the general public
- Facilitate the exchange of clinical experience regarding TMS application
- Publish newsletters, books, audio- and video- materials regarding TMS treatment
- Hold regular symposiums and training programs for TMS and other NIBS.
- Connect with international TMS societies for academic and clinical collaboration
Committies
Teaching Committee
Team Leader：Dr.Tze-Chun Tang
- Online symposium for updated TMS research findings
- TMS certificate program for the excellence of clinical skills
- TMS and Other NIBS Seminars and Workshops (Online/Offline)
Public Relations
Team Leader：Dr.Hung,Chin-Lun
- Publication of TMS case files for the general public
- Social media and press release
- Connect associated academic societies including Taiwanese Society of Neurology and Psychiatry
- International collaboration
Academic Committee
Team Leader：Dr.Chang, Hsin-An
- Association Newsletter
- NIBS Journal Article Selection
- Conference Organization: Annual Meeting, Expert Consensus Meeting, Academic Symposium
- Establishment of rTMS Clinical Database for Analysis
- Focus on the Development of Emerging NIBS Brain Stimulation Techniques
Forward-looking Development
Team Leader：Dr.Yang,Chih-Chieh
Integrating digitalization and artificial intelligence to streamline the clinical processes of NIBS. The main focus will be on the development of treatments for depression, schizophrenia, and migraines.
- Depression：An artificial intelligence EEG platform applied to assess depression symptoms and severity, predict the efficacy of antidepressant medications, and forecast the outcomes of brain stimulation treatments.
- Schizophrenia：An artificial intelligence brain imaging platform applied for accurate diagnosis and symptom assessment of schizophrenia, combined with precise brain stimulation treatment technology.
- Migraine：An AI brainwave platform for predicting the efficacy of brain stimulation treatment for migraines, combined with precise migraine brain stimulation therapy techniques.
President
Executive Council Member
Board Member
Supervisor
How to become a member of TCTMSS?
Membership in the TCTMSS requires a strong passion for research, implementation, and promotion of NIBS brain stimulation treatments. Members should actively participate in the society's affairs, engage in working groups, and collaborate closely with board members and other members.
Membership in the society is by invitation only. Prospective members must be recommended by two board members and approved during the quarterly board meetings.
If you are interested in becoming a TCTMSS member, please first join as a Friend of the Society. Each December, the board invites Friends who are enthusiastic about participating in the society's activities and are willing to contribute to the society's work to become members, working together to advance brain stimulation therapy development in Taiwan.